MAP2K7 and breast carcinoma: A reduction in this signaling pathway has been described in RIAM knockdown melanoma and breast carcinoma cell lines to cause impaired adhesion turnover that correlates with an inhibition of the MEK-ERK pathway and deficient RhoA activation [38].